Amgen, UCB Test Drug On Shuttle | Chemical & Engineering News
Volume 89 Issue 28 | p. 20 | Concentrates
Issue Date: July 11, 2011

Amgen, UCB Test Drug On Shuttle

Department: Business
Keywords: space shuttle, drug discovery

Amgen and UCB are working with NASA’s Ames Research Center to conduct a preclinical test of an antibody aboard space shuttle Atlantis on the final NASA shuttle mission, which at C&EN press time was scheduled to launch on July 8. Using mice, the experiment will assess the effect of a sclerostin antibody on the bone loss associated with spaceflight. A different sclerostin antibody from the two drug companies is currently in Phase II clinical trials for bone-related conditions.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment